Navigation Links
DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board
Date:3/5/2008

LA JOLLA, Calif., March 5 /PRNewswire/ -- DermTech, a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, today announced that Allan C. Halpern, MD, has joined DermTech's Melanoma Advisory Board. Dr. Halpern is Chief of Dermatology at Memorial Sloan-Kettering Cancer Center and widely recognized as an expert in the early detection and management of melanoma in high-risk individuals.

"We are delighted and honored to welcome Dr. Halpern to our Melanoma Advisory Board," said George Schwartz, CEO, DermTech. "Dr. Halpern is a world leader in the area of melanoma and strategies for improved diagnosis and prevention of this disease that, if identified early, has an extremely high cure rate. DermTech will clearly benefit from his significant experience as we move toward clinical trials of our novel, non-invasive molecular diagnostic product for melanoma early detection."

"I am looking forward to working with the company and the outstanding panel of dermatologists and melanoma experts already on this advisory board," said Allan Halpern, MD. Other Melanoma Advisory Board members include: Boris Bastian, MD, David Polsky, MD, PhD, and Harold S. Rabinovitz, MD.

Allan Halpern, MD, is a board-certified internist and dermatologist. In addition to his role as Chief of Dermatology at MSKCC, he is co-leader of the Center's Melanoma Disease Management Team, which incorporates the expertise of doctors in surgery, medical oncology, clinical immunology, dermatology, pathology, and radiation oncology to diagnose and treat melanoma. He pioneered the use of digital whole-body photography to assist in the detection of changing moles in patients with dysplastic nevi (large, irregular colored or shaped moles). Currently, his research is focused on epidemiologic (population-based) studies with a subset of this research devoted to the study of the genetic and environmental factors that influence the development of moles in children and adolescents. Dr. Halpern received his medical degree from the Albert Einstein College of Medicine in New York and completed his Dermatology residency at the Hospital of the University of Pennsylvania. He has presented and published extensively on melanoma detection.

About DermTech:

Headquartered in La Jolla, California, DermTech International is focused on the development and validation of molecular tests using specimens obtained from the skin. The company's proprietary Epidermal Genetic Information Retrieval (EGIR(TM)) technology is in clinical studies to evaluate its potential as a non-invasive diagnostic for melanoma and other major diseases. It is also being studied in the context of tracking treatment efficacy for a variety of dermatologic and other conditions, including the effects of drugs on skin at the molecular level in advance of observable clinical results. DermTech is actively pursuing research using EGIR(TM) and its applications in the areas of melanoma, prostate cancer and various skin disorders, such as psoriasis. For additional information visit http://www.dermtech.com.

Contacts:

DermTech

George Schwartz

CEO

858.450.4222

For DermTech

Jennifer Larson

415.409.2729

jlarson@labfive.com


'/>"/>
SOURCE DermTech
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Radlink Names Allan Christensen Vice President of Technical Services
2. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
3. WorldHeart Appoints David Pellone Chief Financial Officer
4. Mediware Names Thomas K. Mann Chief Executive Officer
5. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
6. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. Coalition America Announces Addition of Mollie Gordon Brown as Chief Strategy Officer
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Karen Vigil Named Senior Vice President and Chief Executive Officer, Blue Shield of Californias Individual, Small Group, and Government Business Unit
11. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health & Wellness ... Moonlight to raise money for the American Heart Association Heart Walk. Teams of up ... work together to keep their treadmills moving for 5 hours. Treadmills will start at ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
(Date:10/12/2017)... ... October 12, 2017 , ... Vohra Chief Medical ... to physician colleagues, skilled nursing facility medical directors and other clinicians at various ... Wound Care." , "At many of these conferences we get to educate other ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated ... latest FDA requirements, which stipulates new criteria regarding medical device manufacture ... Medical ID jewelry such as Medical ID Bracelets, can rest assured ... of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process ...
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
Breaking Medicine Technology: